[PMID: 15247403] PubMed record related to this compound for laboratory literature review
Clinical Studies 14.1 Overview of Clinical Trials BYDUREON has been studied in adult patients with type 2 diabetes mellitus as monotherapy and in combination with metformin, a sulfonylurea, a thiazolidinedione, a combination of metformin and a sulfonylurea, a combination of metformin and a thiazolidinedione, in combination with a SGLT2 inhibitor on a background of metformin, and in combination with basal insulin [see Clinical Studies (14.2, 14.3)]
I wasnt thinking about food all the time, she says
For women of childbearing potential, note that GLP-1 medications for weight management are contraindicated during pregnancy, and some agents should be discontinued at least two months before planned conception
Some research suggests it may enhance GLP-1 receptor activity, but again, human evidence is preliminary